COLL Income Statement - TTM - Collegium Pharmaceutical, Inc.

Income Statement (TTM)

Collegium Pharmaceutical, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	308	310	321	326	326	277	273	314	362	464	525	537	547	567	567	577	599	631	664	707
Change (%)		0.67	3.62	1.52	-0.10	-15.01	-1.43	14.88	15.36	28.27	13.15	2.29	1.81	3.68	0.03	1.72	3.92	5.37	5.20	6.43
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	100	70	58	61	62	59	59	65	69	118	83	81	81	80	79	79	80	84	86	88
Change (%)		-30.30	-17.12	5.22	2.88	-5.27	0.68	8.64	6.45	71.84	-30.11	-1.86	-0.27	-1.39	-0.98	0.56	0.66	4.53	3.03	2.60
% of Revenue	32.38	22.42	17.93	18.59	19.14	21.34	21.79	20.61	19.02	25.48	15.74	15.10	14.79	14.07	13.92	13.77	13.34	13.23	12.96	12.49

Gross Operating Profit	208	241	264	266	263	218	213	249	293	346	442	456	466	487	488	497	519	548	578	619
Change (%)		15.50	9.61	0.71	-0.78	-17.32	-2.01	16.62	17.68	18.04	27.94	3.06	2.18	4.56	0.19	1.90	4.44	5.50	5.53	7.00
% of Revenue	67.62	77.58	82.07	81.41	80.86	78.66	78.21	79.39	80.98	74.52	84.26	84.90	85.21	85.93	86.08	86.23	86.66	86.77	87.04	87.51

SG&A	112	114	114	115	119	119	113	119	127	172	158	159	156	151	148	151	157	183	217	247
Change (%)		1.55	0.19	0.92	3.55	-0.19	-5.37	5.90	6.20	36.00	-8.34	0.75	-1.64	-3.64	-1.52	1.41	4.50	16.34	18.82	13.67
% of Revenue	36.40	36.72	35.50	35.29	36.58	42.97	41.25	38.03	35.01	37.11	30.07	29.62	28.61	26.59	26.18	26.10	26.25	28.98	32.73	34.96

R&D	10	10	10	11	10	9	11	7	6	4	0	0	0
Change (%)		0.76	2.70	9.66	-6.28	-8.37	11.14	-32.96	-20.59	-28.77	-100.00	NaN	NaN
% of Revenue	3.15	3.15	3.12	3.37	3.17	3.41	3.85	2.25	1.55	0.86	0.00	0.00	0.00

OpEx	269	254	249	254	259	255	252	281	312	426	390	390	386	376	370	370	382	432	490	543
Change (%)		-5.69	-1.94	2.02	2.03	-1.69	-1.10	11.52	10.99	36.59	-8.31	-0.10	-1.04	-2.54	-1.60	-0.11	3.19	13.18	13.42	10.81
% of Revenue	87.38	81.86	77.47	77.85	79.51	91.98	92.29	89.59	86.20	91.79	74.38	72.64	70.61	66.37	65.29	64.12	63.67	68.39	73.73	76.76

Operating Income	39	56	72	72	67	22	21	33	50	38	134	147	161	191	197	207	218	200	175	164
Change (%)		44.69	28.69	-0.19	-7.58	-66.73	-5.26	55.07	53.03	-23.67	252.97	9.21	9.37	18.63	3.24	5.15	5.23	-8.30	-12.57	-5.84
% of Revenue	12.62	18.14	22.53	22.15	20.49	8.02	7.71	10.41	13.80	8.21	25.62	27.36	29.39	33.63	34.71	35.88	36.33	31.61	26.27	23.24

Interest Expense	-21	-29	-30	-27	-24	-21	-21	-33	-47	-63	-79	-83	-85	-83	-79	-73	-71	-74	-77	-82
Change (%)		35.24	3.11	-9.53	-10.94	-12.42	0.52	58.42	41.63	33.37	24.67	5.20	2.08	-1.53	-4.91	-7.92	-3.25	4.78	4.67	6.30
% of Revenue	-6.93	-9.32	-9.27	-8.26	-7.37	-7.59	-7.74	-10.67	-13.10	-13.63	-15.01	-15.44	-15.48	-14.70	-13.98	-12.65	-11.78	-11.71	-11.66	-11.64

Net Income	18	27	42	107	104	72	43	-35	-43	-25	-29	-11	9	48	93	100	89	69	44	36
Change (%)		52.06	56.86	154.38	-3.04	-30.91	-40.17	-182.38	21.53	-41.63	17.43	-61.98	-180.78	434.11	93.74	7.07	-11.31	-21.90	-36.56	-17.37
% of Revenue	5.71	8.63	13.06	32.73	31.77	25.83	15.68	-11.24	-11.84	-5.39	-5.59	-2.08	1.65	8.50	16.46	17.32	14.78	10.96	6.61	5.13

Source: Capital IQ

Collegium Pharmaceutical, Inc. - Income Statement (TTM)

Income Statement (TTM)

Other Listings